Segmental Exclusion of the Upper Limb and Peri-personal Space
NCT ID: NCT04778111
Last Updated: 2022-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-05-02
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Exclusion is a phenomenon that is very little studied but known to orthopedic surgeons and physical medicine and rehabilitation physicians. It is characterized by the non-use or underuse of a limb segment in the absence of central nervous system involvement. This phenomenon is compared to peripheral neglect. Most of the time, the patient is unaware of his disorder "he forgets his finger without realizing it", but this phenomenon can be reversible under verbal exhortation from a third party.
The aim of this study is to observe if there is a change in peri-personal space in patients with unilateral segmental exclusion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Several Studys Showed That Upper Limb Amputated Patients Are Able to Experience the Illusion of the Rubber Hand Whith Prosthesis: We Want to go Futher by Comparing the Strength of the Incorporation According to the Type of Prosthesis Using the Illusion of the Rubber Hand With Prothesis
NCT05931198
Effects of Core Stabilization Approach on Patients With Upper Extremity Injuries
NCT01659112
Robotic-assisted Upper Extremity Training in Spinal Cord Injury Patients
NCT03239301
Studying Electromyographic Activity in Patients With Upper Limb Amputations
NCT02956603
Elbow Extension Restoration Surgery in People With Tetraplegia: Evolution of the Muscular Co-activations of the Upper Limb During the Post-operative Rehabilitation
NCT03513783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with exclusion
Measurement of the actual and perceived maximum reachable distance
A device (a table) will present luminous targets (green circles) to the subjects. Subjects will be asked to determine whether or not they are able to reach this target with their upper limb.
Control
Measurement of the actual and perceived maximum reachable distance
A device (a table) will present luminous targets (green circles) to the subjects. Subjects will be asked to determine whether or not they are able to reach this target with their upper limb.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurement of the actual and perceived maximum reachable distance
A device (a table) will present luminous targets (green circles) to the subjects. Subjects will be asked to determine whether or not they are able to reach this target with their upper limb.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person with a symptom of unilateral exclusion.
* Person with no contraindication to hard work in activities of daily living due to the lesions.
* Person who has given informed consent.
Exclusion Criteria
* Person with visual impairment
* A person with a central neurological pathology.
* A person with cognitive impairment related to a brain injury, psychiatric illness or intellectual disability.
* A person who has difficulty understanding instructions.
* A person of full age who is subject to a legal protection measure or who is unable to give consent.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Régional de Médecine Physique et de Réadaptation
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRR-CLP-2021-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.